Cytogen, Inc. (KOSDAQ:217330)
South Korea
· Delayed Price · Currency is KRW
4,380.00
-260.00 (-5.60%)
At close: Mar 9, 2026
Cytogen Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 101,045 | 104,620 | 257,276 | 289,471 | 355,717 |
| Market Cap Growth | -0.23% | -59.34% | -11.12% | -18.62% | - |
| Enterprise Value | 83,951 | 75,039 | 266,578 | 284,261 | - |
| Last Close Price | 4380.00 | 4535.00 | 13520.00 | 16200.00 | 20400.00 |
| PS Ratio | 4.03 | 9.59 | 80.79 | 380.49 | 1022.63 |
| PB Ratio | 2.43 | 2.14 | 4.82 | 51.18 | 15.46 |
| P/TBV Ratio | 3.58 | 2.98 | 5.62 | - | 16.54 |
| EV/Sales Ratio | 3.35 | 6.88 | 83.72 | 373.65 | - |
| Debt / Equity Ratio | 0.38 | 0.30 | 0.33 | 4.67 | 1.07 |
| Net Debt / Equity Ratio | -0.42 | -0.54 | -0.70 | 1.50 | -0.49 |
| Net Debt / EBITDA Ratio | 3.72 | 3.08 | 3.78 | -0.83 | 0.95 |
| Net Debt / FCF Ratio | 1.88 | 2.51 | 3.70 | -1.21 | 1.73 |
| Asset Turnover | 0.33 | 0.15 | 0.06 | 0.02 | - |
| Inventory Turnover | 8.48 | 9.24 | 29.83 | - | - |
| Quick Ratio | 2.89 | 9.71 | 5.18 | 0.55 | 5.31 |
| Current Ratio | 3.16 | 10.20 | 5.21 | 0.57 | 6.42 |
| Return on Equity (ROE) | -30.41% | -33.46% | -53.45% | -130.97% | - |
| Return on Assets (ROA) | -6.16% | -9.07% | -12.74% | -14.85% | - |
| Return on Capital Employed (ROCE) | -13.90% | -15.70% | -18.50% | -157.70% | -26.40% |
| Earnings Yield | -15.07% | -16.36% | -6.13% | -6.49% | -3.06% |
| FCF Yield | -9.23% | -10.07% | -3.92% | -2.43% | -1.81% |
| Buyback Yield / Dilution | -6.90% | -23.54% | -3.54% | -4.24% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.